BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18799953)

  • 1. Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.
    de Carvalho MN; Nobre F; Mendes MC; Dos Reis RM; Ferriani RA; Silva de Sá MF
    Blood Press Monit; 2008 Oct; 13(5):277-83. PubMed ID: 18799953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
    Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
    Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
    Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C; Dinçer Cengiz S; Cengiz B; Akgün G
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes.
    Cunha EP; Azevedo LH; Pompei LM; Strufaldi R; Steiner ML; Ferreira JA; Peixoto S; Fernandes CE
    Climacteric; 2010 Aug; 13(4):362-7. PubMed ID: 20151792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
    Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure monitoring in renal transplant patients: modifiable parameters after active antihypertensive treatment.
    Oliveras A; Vázquez S; Hurtado S; Vila J; Puig JM; Lloveras J
    Transplant Proc; 2004 Jun; 36(5):1352-4. PubMed ID: 15251330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.
    Spritzer PM; Vitola D; Vilodre LC; Wender MC; Reis FM; Ruschel S; Castro I
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):267-73. PubMed ID: 12951632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
    Cano A; Calaf J; Molina J
    Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
    Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
    Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
    Kawecka-Jaszcz K; Czarnecka D; Olszanecka A; Rajzer M; Jankowski P
    J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
    Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Smetnik VP; Slasten OP
    Ter Arkh; 2001; 73(10):33-8. PubMed ID: 11763512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
    White WB; Pitt B; Preston RA; Hanes V
    Circulation; 2005 Sep; 112(13):1979-84. PubMed ID: 16186434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.